Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001

Canadian Journal of Microbiology

Volumn 49, Issue 10, 2003, Pages 633-638

  Tsang, R S W ^a   Squires, S G ^b   Tam, T W S ^b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b HEALTH CANADA   (Canada)

Author keywords

Antigenic; Characterization; Genetic; Meningococci

Indexed keywords

ANTIGENS; COMPOSITION; DISEASES; ELECTROPHORESIS; EPIDEMIOLOGY; PATIENT TREATMENT; POLYSACCHARIDES; VACCINES;

ANTIGENIC COMPOSITION; SEROTYPES;

BACTERIA;

ANTIGEN;

ANTIGEN; BACTERIAL DISEASE; VACCINATION;

ARTICLE; BACTERIAL STRAIN; BLOOD GROUP TYPING; CANADA; CONTROLLED STUDY; EPIDEMIC; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SEROTYPE;

BACTERIAL TYPING TECHNIQUES; CANADA; DISEASE OUTBREAKS; HUMANS; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; POPULATION SURVEILLANCE; SEROTYPING;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; NEISSERIA; NEISSERIA MENINGITIDIS;

EID: 1042291077     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/w03-074     Document Type: Article

References (43)

1. Abdillahi, H., and Poolman, J.T. 1987. Whole-cell ELISA for typing of Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol. Lett. 48: 367-371.
2. Advisory Committee on Epidemiology. 2000. Case definitions for diseases under national surveillance. Canada Communicable Disease Report, 26S3: 49.
3. Armand, J., Armiknjon, F., Mynard, M.C., and Lafaix, C. 1982. Tetravalent meningococcal polysaccharide vaccine groups A, C, Y, W135: clinical and serological evaluation. J. Biol. Stand. 10: 335-339.
4. Arreaza, L., Berron, S., Fernandez, S., Santiago, M.L., Malvar, A., and Vazquez, J.A. 2000. Investigation for a more virulent variant among the C:2b:P1.2,5 Spanish meningococcal epidemic strains by molecular epidemiology. J. Med. Microbiol. 49: 1079-1084.
5. Artenstein, M.S., Gold, R., Zimmerly, J.G., Wyle, F.A., Schneider, H., and Harkins, C. 1970. Prevention of meningococcal disease by group C polysaccharide vaccine. N. Engl. J. Med. 282: 417-420.
6. Ashton, F.E., and Caugant, D.A. 2001. The panmictic nature of Neisseria meningitidis serogroup B during a period of endemic disease in Canada. Can. J. Microbiol. 47: 283-289.
7. Ashton, F.E., Ryan, J.A., Borczyk, A., Caugant, D.A., Mancino, L., and Huang, D. 1991. Emergency of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal serogroup C disease in Canada. J. Clin. Microbiol. 29: 2489-2493.
8. Berron, S., De La Fuente, L., Martin, E., and Vazquez, J.A. 1998. Increasing incidence of meningococcal disease in Spain associated with a new variant of serogroup C. Eur. J. Clin. Microbiol. Infect. Dis. 17: 85-89.
9. Caugant, D. A. 1998. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS, 106: 505-525.
10. Clarke, S.C., Reid, J., Thom, L., Denham, B.C., and Edwards, G.F. 2001. Meningococcal disease due to serogroup Y in Scotland, 1992-1999. Br. J. Biomed. Sci. 58: 17-19.
11. Claus, H., Vogel, U., Muhlenhoff, M., Gerardy-Schahn, R., and Frosch, M. 1997. Molecular divergence of the sia locus in different serogroups of Neisseria meningitidis expressing polysialiac acid capsules. Mol. Gen. Genet. 257: 28-34.
12. De Wals, P., De Serres, G., and Niyonsenga, T. 2001. Effectiveness of a mass immunization campaign against serogroup C meningococcal disease.in Quebec. JAMA (J. Am. Med. Assoc.), 285: 177-181.
13. English, M., Maclennan, J.M., Bowen-Morris, J.M., Deeks, J., Boardman, M., Brown, K., Smith, S., Buttery, J., Clarke, J., Quataert, S., Lockhart, S., and Moxon, E.R. 2000. Randomized, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants. Vaccine, 19: 1232-1238.
14. Frasch, C.E., Zollinger, W.D., and Poolman, J.T. 1985. Serotyping antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis. 7: 504-510.
15. Gold, R., Lepow, M.L., Goldschneider, I., Draper, T.L., and Gotschlich, E.C. 1975. Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants. J. Clin. Investig. 56: 1536-1547.
16. Goldschneider, I., Lepow, M.L., and Gotschlich, E.C. 1971. Immunogenicity of the group A and group C meningococcal polysaccharides in children. J. Infect. Dis. 125: 509-519.
17. Hahne, S.J.M., Gray, S.J., Aguilera, J.F., Crowcroft, N.S., Nichols, T., Kaczmarski, E.B., and Ramsay, M.E. 2002. W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001. Lancet, 359: 582-583.
18. Jelfs, J., Jalaludin, B., Munro, R., Patel, M., Kerr, M., Daley, D., Neville, S., and Capron, A. 1998. A cluster of meningococcal disease in western Syndey, Australia initially associated with a nightclub. Epidemiol. Infect. 120: 263-270.
19. Jelfs, J., Munro, R., Ashton, F.E., and Caugant, D.A. 2000. Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world. Epidemiol. Infect. 125: 285-298.
20. Klaber, R., Booy, R., El Bashir, H., Mifsud, A., and Taylor, S. 2002. Sustained outbreak of W135 meningococcal disease in east London, U.K. Lancet, 360: 644.
21. Krizova, P., and Musilek, M. 1995. Changing epidemiology of meningococcal invasive disease in the Czech Republic caused by new clone Neisseria meningitidis C:2a:P1.2(5), ET-15/37. Cent. Eur. J. Public Health, 4: 189-194.
22. Lindberg, A.A. 1999. Glycoprotein conjugate vaccines. Vaccine, 17(Suppl. 2): S28-S36.
23. Pollard, A.J., and Tam, T.W.S. 2001. Statement on recommended use of meningococcal vaccines. Canada Communicable Disease Report, 27: 2-36.
24. Public Health Laboratory Service - Communicable Disease Surveillance Centre. 1999/2000. Review of Communicable Diseases - England and Wales. Available from (http://www.phls. org.uk/publications/annual_reviewindex.htm) [accessed on August 26, 2003].
25. Ramsay, M., Kaczmarski, E., Rush, M., Mallard, R., Farrington, P., and White, I. 1997. Changing patterns of case management and trends in meningococcal disease in England and Wales. Commun. Dis. Rep. CDR Rev. 7: R49-R54.
26. Raymond, N.J., Reeves, M., Ajello, G., Baughman, W., Ghessling, L.L., Carlone, G.M., Wenger, J.D., and Stephens, D.S. 1997. Molecular epidemiology of sporadic (endemic) serogroup C meningococcal disease. J. Infect. Dis. 176: 1277-1284.
27. Sacchi, C.T., Lemos, A.P.S., Whitney, A.M., Solari, C.A., Brandt, M.E., Melles, C.E.A., Frasch, C.E., and Mayer, L.W. 1998. Correlation between serological and sequencing analysis of the PorB outer membrane protein in the Neisseria meningitidis serotyping system. Clin. Diagn. Lab. Immunol. 5: 348-354.
28. Selander, R.K., Caugant, D.A., Ochman, H., Musser, J.M., Gilmour, M.N., and Whittam, T.S. 1986. Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl. Environ. Microbiol. 51: 873-884.
29. Smith, I., Lehman, A.K., Lie, L., Digranes, A., Caugant, D.A., Hoiby, E.A., Froholm, L.O., and Halstensen, A. 1999. Outbreak of meningococcal disease in Western Norway due to a new serogroup C variant of the ET-clone: effect of vaccination and selective carriage eradication. Epidemiol. Infect. 123: 373-382.
30. Squires, S.G., Pelletier, L., Mungai, M., Tsang, R., Collins, F., and Stoltz, J. 2000. Invasive meningococcal disesae in Canada, 1 January 1997 to 31 December 1998. Canadian Communicable Disease Report, 26: 177-182.
31. Swaminathan, B., Matar, G.M., Reeves, M.W., Graves, L.M., Ajello, G., Bibb, W.F., Helsel, L.O., Morales, M., Dronavalli, H., El-Swify, M., DeWitt, W., and Hunter, S.B. 1996. Molecular subtyping of Neisseria meningitidis serogroup B: comparison of five methods. J. Clin. Microbiol. 34: 1468-1473.
32. Taha, M.K., Achtman, M., Alonso, J.M., Greenwood, B., Ramsay, M., Fox, A., Gray, S., and Kaczmarski, E. 2000. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet, 356: 2159.
33. Tapsall, J., and the Australian Meningococcal Surveillance Programme. 2002. Annual report of the Australian meningococcal surveillance programme, 2001. Commun. Dis. Intell. 26: 407-418.
34. Tribe, D.E., Zaia, A.M., Griffith, J.M., Robinson, P.M., Li, H.Y., Taylor, K.N., and Hogg, G.G. 2002. Increase in meningococcal disease associated with the emergence of a novel ST-11 variant of serogroup C Neisseria meningitidis in Victoria, Australia, 1999-2000. Epidemiol. Infect. 128: 7-14.
35. Tsang, R.S.W., Law, D., and Squires, S.G. 2001. Two serologically non-groupable Neisseria meningitidis strains from clinical specimens identified by molecular method as serogroup B. Canadian Communicable Disease Report, 27: 9-12.
36. Tsang, R.S.W., Squires S.G., Zollinger, W.D., and Ashton F.E. 2002. Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001. Can. J. Infect. Dis. 13: 391-396.
37. Tsang, R.S.W., Kiefer, L., Law, D.K.S., Stoltz, J., Shahin, R., Brown, S., and Jamieson, F. 2003. Outbreak of serogroup C meningococcal disease caused by a variant of Neisseria meningitidis serotype 2a ET-15 in a community of men who have sex with men. J. Clin. Microbiol. 41: 4411-4414.
38. Tsang, R.S.W., Squires, S.G., and Tam, T.W.S. 2003. Unpublished data.
39. Tyrrell, G.J., Chui, L., Johnson, M., Chang, N., Rennie, R.P., and Talbot, J.A. 2002. Outbreak of Neisseria meningitidis, Edmonton, Alberta, Canada. Emerg. Infect. Dis. 8: 519-521.
40. Urwin, R., Holmes, E.C., Fox, A.J., Derrick, J.P., and Maiden, M.C.J. 2002. Phylogenetic evidence for frequent positive selection and recombination in the meningococcal surface antigen PorB. Mol. Biol. Evol. 19: 1686-1694.
41. Vedros, N.A. 1987. Development of meningococcal serogroups. In Evolution of meningococcal disease. Edited by N.A. Vedros. CRC Press, Boca Raton, Fla. pp. 33-37.
42. Whalen, C.M., Hockin, J.C., Ryan, A., and Ashton, F. 1995. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. JAMA (J. Am. Med. Assoc.), 273: 390-394.
43. Wilder-Smith, A., Barkham, T.M.S., Earnest, A., and Paton, N.I. 2002. Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study. BMJ, 325: 365-366.